Overview

Esmolol in Cardiac Surgery

Status:
Completed

Trial end date:
2018-06-01

Target enrollment:

Participant gender:

Summary

This large randomized double-blind clinical trial (esmolol vs placebo) will enroll patients undergoing cardiac surgery to study the additive cardiac protection of this therapeutic strategy.

Phase:

Phase 4

Details

Lead Sponsor:

Università Vita-Salute San Raffaele

Treatments:

Adrenergic beta-Antagonists
Esmolol